John Schieszer, MA

The risk of virtually all early postoperative complications increases with increasing patient age at radical prostatectomy for localized prostate cancer.

Continuous therapy appears to be the preferred treatment modality in newly diagnosed patients with multiple myeloma (MM).

A review of DBBR data demonstrated that regular recreational physical activity may reduce the risk of all-cause and cancer-specific mortality in persons who are habitually active as a lifestyle as well as those who adopt regular exercise as a lifestyle after diagnosis.

Mean changes in hematologic indices found similar regardless of same-day or prior administration of B12 supplementation in patients receiving pemetrexed for NSCLC or pleural mesothelioma.

In this retrospective study, researchers sought to determine the efficacy of nedaplatin vs cisplatin for the treatment of malignancy-induced malignant pleural effusion.

An international team reviews osimertinib-associated dermatologic adverse events in patients treated with the third-generation EGFR-TKI.

In a recent report, researchers evaluate the efficacy of newer 5HT3-RAs for the prevention of CINV in patients with cancer receiving moderately or highly emetogenic chemotherapy.

In a randomization of women with early-stage breast cancer, researchers explored the potential benefits of chemotherapy for women whose Oncotype DX RS was midrange.

Four of 9 lung cancer screening models were shown to effectively select the most appropriate candidates for low-dose CT lung cancer screening among US ever-smokers.

In updating its 2012 recommendations, the US Preventive Services Task Force changes its stance on PSA-based screening for prostate cancer in men older than 50. The new guidelines advocate for a patient-physician discussion of the benefits of testing vs the potential harms.